Previous 10 | Next 10 |
home / stock / biovf / biovf news
STOCKHOLM , May 7, 2020 /PRNewswire/ -- Sobi™ announced today that the results from the pivotal phase 2/3 study evaluating the efficacy and safety of emapalumab in patients with primary haemophagocytic lymphohistiocytosis (HLH) were published in the New England Journal of ...
Swedish Orphan Biovitrum AB (publ) (BIOVF) Q1 2020 Earnings Conference Call April 29, 2020 07:00 AM ET Company Participants Guido Oelkers - Chief Executive Officer Henrik Stenqvist - Chief Financial Officer Milan Zdravkovic - Head-Research and Development Conference Call Parti...
The China National Medical Products Administration has approved Dova Pharmaceuticals' Doptelet (avatrombopag) for chronic liver disease patients with thrombocytopenia (low blood platelets) who are undergoing a procedure. More news on: Swedish Orphan Biovitrum AB (publ), Healthcare stocks...
The following slide deck was published by Swedish Orphan Biovitrum AB (publ) in conjunction with their 2020 Q1 earnings Read more ...
STOCKHOLM , April 22, 2020 /PRNewswire/ -- On 29 April, at 08:00 CET , Swedish Orphan Biovitrum AB (publ) (Sobi™) will publish its report for the first quarter 2020. Financial analysts and media are invited to participate in a telephone conference, which will include a pre...
STOCKHOLM , April 22, 2020 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) has today announced the launch by its affiliate, Florio GmbH, of Florio®, a digital medical device designed with the aim to improve the quality of life for people with haemophilia. Consist...
STOCKHOLM , April 20, 2020 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) hereby informs that the shareholders may exercise their voting rights at the 2020 annual general meeting by voting in advance, so-called postal voting. Sobi urges shareholders to exercise this o...
Swedish Orphan Biovitrum ( OTCPK:BIOVF ) announced that the preliminary revenue and EBITA in March are impacted by increases in demand related to the ongoing COVID-19 pandemic. More news on: Swedish Orphan Biovitrum AB (publ), , Read more ...
The European Medicines Agency's advisory group CHMP has adopted positive opinions recommending label extensions for the following drugs: More news on: Takeda Pharmaceutical Company Limited, Novartis AG, Johnson & Johnson, Healthcare stocks news, Read more ...
STOCKHOLM , Feb. 28, 2020 /PRNewswire/ -- According to a new survey from rare disease company Sobi, 28 per cent of people living with a rare condition, and their caregivers, say the disease has caused a relationship to end. 41 percent state that a rare disease has prevented them from sta...
News, Short Squeeze, Breakout and More Instantly...
Swedish Orphan Biovit Ord Company Name:
BIOVF Stock Symbol:
OTCMKTS Market:
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...
CenterPoint Energy Inc (Holding Co) (CNP) is expected to report $0.37 for Q3 2023 The Hershey Company (HSY) is expected to report $2.47 for Q3 2023 ASE Technology Holding Co. Ltd. American Depositary Shares (each representing Two) (ASX) is expected to report for Q3 2023 Reliance Steel...
Swedish Orphan Biovitrum AB (BIOVF) is expected to report $0.09 for Q3 2023